Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism DAT antagonists(Dopamine transporter antagonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H24INO2 |
InChIKeyYYCOWMQMXNLRHZ-JCEKTBGXSA-N |
CAS Registry311767-40-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | SE | 03 Jun 2003 |
Not Applicable | - | (Parkinson’s disease patients) | ercjychegp(slrahnvtyl) = mhpdlxkosc zodmruacmz (dihvvlxgvy, 8.78) View more | - | 28 Aug 2023 | ||
(Healthy controls) | ercjychegp(slrahnvtyl) = ynpfmxwmjg zodmruacmz (dihvvlxgvy, 4.95) View more |